Finished product reference
Amino Acid 10% (3)
Injection, Solution · Intravenous · 5.8 mg/12 mg/16.925 mg/2 mg/3.5 mg/8.2 mg/3 mg/8.7 mg/8.2 mg/9.8 mg/6.2 mg/0.4 mg/5.305 mg/3 mg/7.6 mg/0.6 mg/3.155 mg/2.01 mg/1mL · 250 mL
- List code
- 52896
- Pharmacologic class
- Parenteral nutrition; amino acid solution (10%)
What it is and how it works
A sterile solution of essential and non-essential L-amino acids that provides a nitrogen source for protein synthesis and tissue repair in patients unable to receive adequate enteral nutrition.
Indications
Source of amino acids as part of parenteral nutrition in adults when oral or enteral nutrition is impossible, insufficient or contraindicated.
Dosage and administration (summary)
Dosing is individualised by the nutrition team according to protein requirements, clinical condition and protocol; given by intravenous infusion, usually with energy sources (glucose, lipid), electrolytes, vitamins and trace elements.
Contraindications
Congenital abnormalities of amino acid metabolism; severe hepatic insufficiency or hepatic coma; severe renal insufficiency without access to dialysis; unstable circulatory states such as shock.
Warnings and precautions
Monitor fluid balance, electrolytes, acid-base status, blood glucose, liver and renal function. Infuse at a controlled rate; too rapid infusion may cause nausea, vomiting and flushing. Strict aseptic technique is required, and refeeding syndrome should be anticipated in malnourished patients.
Pregnancy
May be used in pregnancy when parenteral nutrition is clinically required.
Storage and supply
Store below 25 °C, protected from light; do not freeze.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Other presentations of the same active ingredient
- Injection, Solution · Intravenous · 5 g/7.4 g/9.31 g/4.3 g/5.1 g/4.4 g/2 g/6.2 g/12 g/3 g/14 g/11 g/11.2 g/6.5 g/0.4 g/1 g/1000mL · 500 mL20081
- Injection, Solution · Intravenous · 5 mg/8.9 mg/5.74 mg/3.12 mg/4.4 mg/4.7 mg/4.2 mg/1.6 mg/6.2 mg/11.5 mg/3 mg/10.5 mg/12 mg/5.6 mg/7.2 mg/5.5 mg/2.3 mg/0.4 mg/1mL · 1000 mL52272
- Injection, Solution · Intravenous · 5 mg/8.9 mg/5.74 mg/3.12 mg/4.4 mg/4.7 mg/4.2 mg/1.6 mg/6.2 mg/11.5 mg/3 mg/10.5 mg/12 mg/5.6 mg/7.2 mg/5.5 mg/2.3 mg/0.4 mg/1mL · 250 mL14115
- Injection, Solution · Intravenous · 5 mg/8.9 mg/5.74 mg/3.12 mg/4.4 mg/4.7 mg/4.2 mg/1.6 mg/6.2 mg/11.5 mg/3 mg/10.5 mg/12 mg/5.6 mg/7.2 mg/5.5 mg/2.3 mg/0.4 mg/1mL · 500 mL52340
- Injection, Solution · Intravenous · 5.8 mg/12 mg/16.925 mg/2 mg/3.5 mg/8.2 mg/3 mg/8.7 mg/8.2 mg/9.8 mg/6.2 mg/0.4 mg/5.305 mg/3 mg/7.6 mg/0.6 mg/3.155 mg/2.01 mg/1mL · 500 mL52897
- Injection, Solution · Intravenous · 5.85 mg/11.4 mg/7.95 mg/5.7 mg/5.7 mg/5.4 mg/2.1 mg/7.2 mg/16.05 mg/5.25 mg/22.35 mg/19.2 mg/7.95 mg/16.2 mg/7.35 mg/3 mg/0.5 mg/0.5 mg/1mL · 500 mL52209
- Injection, Solution · Intravenous · 2.5 mg/3.7 mg/4.655 mg/2.15 mg/2.55 mg/2.2 mg/1 mg/3.1 mg/6 mg/1.5 mg/7 mg/5.5 mg/5.6 mg/3.25 mg/0.2 mg/0.5 mg/1mL · 500 mL50865
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.